RSNA 2017 News

FDA clears Perspectum Diagnostics' LiverMultiScan

By staff writers
November 27, 2017

Image analysis software developer Perspectum Diagnostics has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its LiverMultiScan postprocessing software for MRI of the liver, delivered through a cloud-based service.

LiverMultiScan may now be used on a wider range of scanners, including compatible Siemens Healthineers and Philips Healthcare MRI systems, to help clinicians quantitatively measure liver tissue to assist with diagnosing liver disease, according to the firm.

Using multiparametric mapping techniques, the software enables noninvasive and quantitative liver tissue characterization to quantify liver fat, as well as T2* and iron-corrected T1. The technology is scalable and can be integrated into existing MRI exams, without the need for a contrast agent, the company noted.

Oxford spin-off prepares MRI liver software for market
Perspectum Diagnostics, a start-up company spun off from Oxford University in the U.K., is preparing to unveil a new software application designed to...

Copyright © 2017

Last Updated np 4/13/2018 11:02:54 AM